Related Experiment Video
Updated: Aug 19, 2026
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
[Resistance testing of cytostatic agents on human tumors (author's transl)]
Abstract:
An in vitro short term incubation of human tumors with different cytostatic agents and their corresponding radioactive precursors of cell metabolism allows detection of those drugs which are inefficacious on the examined tumor. The pretherapeutical knowledge of those substances keeps the patient from unnecessary and damaging cytotoxic treatment. The in vitro and in vivo correlation of this technique was tested on 3 different groups of tumor patients: 1. Chemotherapeutically treated tumor patients with primary or secondary induced resistance against the applied cytostatic agents: all substances which clinically did not influence the tumor growth at the moment of the test also were inefficient in the in vitro test system. 2. Tumor patients who were treated according to a clinical therapy regimen contrary to the results of the in vitro testing: corresponding to the test, no influence on tumor growth was seen. 3. Tumor patients who were treated according to the results of the resistance test: after 8 weeks observation none of these patients had any signs of tumor progression.
Insights
This study introduces an in vitro method to predict ineffective chemotherapy drugs for individual human tumors. This approach helps avoid unnecessary, damaging treatments and guides effective patient therapy, improving outcomes.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Context:
- Chemotherapy resistance is a major challenge in cancer treatment, leading to ineffective therapies and patient harm.
- Predicting drug efficacy before treatment is crucial for personalized medicine.
Purpose:
- To evaluate an in vitro drug sensitivity testing method for predicting cytostatic agent efficacy in human tumors.
- To correlate in vitro test results with in vivo clinical outcomes in cancer patients.
Summary:
- An in vitro short-term incubation assay was developed to identify ineffective cytostatic drugs for specific human tumors by analyzing their interaction with radioactive precursors of cell metabolism.
- The study validated this technique across three patient groups, demonstrating high concordance between in vitro predictions and clinical responses, including resistance and treatment success.
- Patients treated based on in vitro resistance test results showed no tumor progression after 8 weeks, indicating the method's clinical utility.
Impact:
- This predictive assay can significantly improve patient outcomes by preventing exposure to ineffective and toxic chemotherapy.
- Enables personalized treatment strategies, optimizing drug selection and reducing healthcare costs associated with failed therapies.
- Facilitates the development of targeted cancer therapies by providing a reliable tool for drug screening and resistance assessment.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
Related Concept Videos
02:56Treatment Resistant Cancers
02:56Treatment Resistent Cancers